Dengue Vaccines Market 2022: Future Demand, Market Analysis and Outlook to 2028 | Sanofi, Takeda Pharmaceutical Co. ltd.
SEATTLE , WASHINGTON, UNITED STATES, January 7, 2022 /EINPresswire.com/ -- 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰 Dengvaxia (CYD-TDV) was first licensed in Mexico in December 2015 for use in individuals 9-45 years of age living in endemic areas, and is now licensed in 20 countries …